Dianne Feinstein sold Bio-Techne Corp (NASDAQ: TECH)
Dianne Feinstein (D-CA), a U.S. Senator, has disclosed 1 trade in Bio-Techne Corp (TECH) since 2018, a single sale, worth an estimated $750K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Dianne Feinstein sold $500,001 - $1,000,000 of Bio-Techne Corp (NASDAQ: TECH) on April 20, 2018. Since that trade, TECH is up +97.29% against the S&P 500 up +209.62%, an outperformance of -112.33%.
Data updated
Dianne Feinstein's TECH trades vs the price
TECH is up +97.29% since Dianne Feinstein sold on April 20, 2018, versus +209.62% for the S&P 500.
Performance since this trade
All Dianne Feinstein TECH trades
Dianne Feinstein & TECH trading FAQ
Is it legal for Dianne Feinstein to trade Bio-Techne Corp (TECH) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bio-Techne Corp (TECH), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Dianne Feinstein sell TECH?
Dianne Feinstein disclosed a sale of $500,001 - $1,000,000 of Bio-Techne Corp (TECH) on April 20, 2018, according to public STOCK Act filings.
How has TECH performed since Dianne Feinstein's trade?
Since Dianne Feinstein sold TECH on April 20, 2018, the stock is up +97.29%, versus +209.62% for the S&P 500 over the same period, an outperformance of -112.33%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional TECH trades?
Quantellect tracks every disclosed congressional trade in Bio-Techne Corp (TECH) on the Bio-Techne Corp congressional trading page, which aggregates filings across all members of Congress.
Dianne Feinstein's TECH tradesAll congressional filings for Bio-Techne CorpDianne Feinstein's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.